Lodder Mariette C, Haugeberg Glenn, Lems Willem F, Uhlig Till, Orstavik Ragnhild E, Kostense Piet J, Dijkmans Ben A C, Kvien Tore K, Woolf Anthony D
Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands.
Arthritis Rheum. 2003 Apr 15;49(2):209-15. doi: 10.1002/art.10996.
To examine variables associated with bone mineral density (BMD) and vertebral deformities in women with rheumatoid arthritis (RA) from 3 northwest European countries.
Female patients were recruited from rheumatology clinics in Oslo, Norway; Truro, UK; and Amsterdam, The Netherlands (150 total, 50 per center, age 50-70 years, disease duration > or = 5 years). Demographic and clinical data were collected and BMD was measured by means of dual energy x-ray absorptiometry. Associations between demographic and clinical measures on the one hand and BMD and vertebral deformities on the other were investigated by single and multiple regression analyses.
Body mass index (BMI), medication use, RA damage measures, and BMD differed significantly between the 3 centers. Overall, Norwegian patients had the lowest BMI, used more corticosteroids and anti-osteoporotic drugs, had lower joint damage measured by Larsen score, and lower BMD at both spine and hip. High age, low BMI, and high cumulative dose of corticosteroids (last 2 years) are related to low BMD. A high Larsen score was associated with low BMD at the hip. Larsen score was the independent determinant of vertebral deformities after correction for center, age, BMI, and BMD.
Data from 3 countries on BMD and vertebral deformities in female patients aged 50-70 years with longstanding RA are presented, demonstrating an association between radiographic RA damage and low BMD and between radiographic RA damage and vertebral deformities.
研究来自3个西北欧国家的类风湿关节炎(RA)女性患者中与骨密度(BMD)及椎体畸形相关的变量。
从挪威奥斯陆、英国特鲁罗和荷兰阿姆斯特丹的风湿病诊所招募女性患者(共150例,每个中心50例,年龄50 - 70岁,病程≥5年)。收集人口统计学和临床数据,并通过双能X线吸收法测量骨密度。通过单因素和多因素回归分析研究人口统计学和临床指标与骨密度及椎体畸形之间的关联。
3个中心之间的体重指数(BMI)、药物使用情况、RA损伤指标和骨密度存在显著差异。总体而言,挪威患者的BMI最低,使用更多的皮质类固醇和抗骨质疏松药物,通过Larsen评分测量的关节损伤较低,脊柱和髋部的骨密度也较低。高龄、低BMI以及皮质类固醇的高累积剂量(过去2年)与低骨密度相关。高Larsen评分与髋部低骨密度相关。在校正中心、年龄、BMI和骨密度后,Larsen评分是椎体畸形的独立决定因素。
呈现了来自3个国家的50 - 70岁长期患RA女性患者的骨密度和椎体畸形数据,表明影像学RA损伤与低骨密度之间以及影像学RA损伤与椎体畸形之间存在关联。